Detalhe da pesquisa
1.
Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
Infection
; 51(1): 231-238, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36195695
2.
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
Br J Cancer
; 127(5): 836-843, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35637412
3.
Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission.
Infection
; 50(3): 635-642, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716901
4.
Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients.
Eur Respir J
; 58(1)2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602859
5.
Coincidental SARS-CoV-2 infection and mRNA vaccination: a case report addressing the most important clinical questions.
Infection
; 49(4): 785-788, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963523
6.
[Acute Facial Swelling Following Dental Procedure - an Allergic Reaction?] / Akute Gesichtsschwellung nach Zahnbehandlung: eine allergische Reaktion?
Anasthesiol Intensivmed Notfallmed Schmerzther
; 54(6): 435-438, 2019 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-31212334
7.
Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer.
Anticancer Drugs
; 28(7): 717-722, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28582279
8.
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial.
Lancet Oncol
; 17(10): 1426-1434, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27575024
9.
The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance.
Acta Oncol
; 55(3): 318-28, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26098842
10.
Economic evaluation of genetic screening for Lynch syndrome in Germany.
Genet Med
; 17(10): 765-73, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25569434
11.
Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.
Tumour Biol
; 36(10): 7897-906, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25953265
12.
KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer.
Future Oncol
; 11(13): 1919-29, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26161928
13.
COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor Outcome.
Oncol Res Treat
; 47(3): 88-96, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967545
14.
ChatGPT's Gastrointestinal Tumor Board Tango: A limping dance partner?
Eur J Cancer
; 205: 114100, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729055
15.
Treatment of Mediastinal Endometrial Carcinoma Developed from Extragenital Endometriosis and Simultaneous Rectal Adenocarcinoma in a 55-year-old Woman.
Anticancer Res
; 43(4): 1857-1861, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974819
16.
Baseline Health-related Quality of Life Predicts Bladder Cancer-specific Survival Following Radical Cystectomy.
Eur Urol Focus
; 8(6): 1659-1665, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184991
17.
Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy.
Cancers (Basel)
; 14(3)2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158793
18.
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial.
Front Oncol
; 12: 751453, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35251955
19.
Analysis of Circulating Immune Subsets in Primary Colorectal Cancer.
Cancers (Basel)
; 14(24)2022 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551592
20.
First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer - Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110).
Eur J Cancer
; 173: 194-203, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35940054